GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biofil Chemicals & Pharmaceuticals Ltd (BOM:524396) » Definitions » Cyclically Adjusted PS Ratio

Biofil Chemicals & Pharmaceuticals (BOM:524396) Cyclically Adjusted PS Ratio : 3.60 (As of May. 28, 2024)


View and export this data going back to 1994. Start your Free Trial

What is Biofil Chemicals & Pharmaceuticals Cyclically Adjusted PS Ratio?

As of today (2024-05-28), Biofil Chemicals & Pharmaceuticals's current share price is ₹63.82. Biofil Chemicals & Pharmaceuticals's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was ₹17.71. Biofil Chemicals & Pharmaceuticals's Cyclically Adjusted PS Ratio for today is 3.60.

The historical rank and industry rank for Biofil Chemicals & Pharmaceuticals's Cyclically Adjusted PS Ratio or its related term are showing as below:

BOM:524396' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 2.6   Med: 3.87   Max: 28.16
Current: 3.72

During the past years, Biofil Chemicals & Pharmaceuticals's highest Cyclically Adjusted PS Ratio was 28.16. The lowest was 2.60. And the median was 3.87.

BOM:524396's Cyclically Adjusted PS Ratio is ranked worse than
72.01% of 743 companies
in the Drug Manufacturers industry
Industry Median: 2.09 vs BOM:524396: 3.72

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Biofil Chemicals & Pharmaceuticals's adjusted revenue per share data for the three months ended in Dec. 2023 was ₹3.236. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₹17.71 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Biofil Chemicals & Pharmaceuticals Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Biofil Chemicals & Pharmaceuticals's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biofil Chemicals & Pharmaceuticals Cyclically Adjusted PS Ratio Chart

Biofil Chemicals & Pharmaceuticals Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 5.04 4.16 2.60

Biofil Chemicals & Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.60 2.60 2.71 2.77 3.05

Competitive Comparison of Biofil Chemicals & Pharmaceuticals's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Biofil Chemicals & Pharmaceuticals's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biofil Chemicals & Pharmaceuticals's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biofil Chemicals & Pharmaceuticals's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Biofil Chemicals & Pharmaceuticals's Cyclically Adjusted PS Ratio falls into.



Biofil Chemicals & Pharmaceuticals Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Biofil Chemicals & Pharmaceuticals's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=63.82/17.71
=3.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biofil Chemicals & Pharmaceuticals's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Biofil Chemicals & Pharmaceuticals's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=3.236/152.9243*152.9243
=3.236

Current CPI (Dec. 2023) = 152.9243.

Biofil Chemicals & Pharmaceuticals Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 2.867 91.425 4.796
201406 0.308 94.103 0.501
201409 0.440 96.780 0.695
201412 0.535 96.780 0.845
201503 2.325 97.163 3.659
201506 0.425 99.841 0.651
201509 0.346 101.753 0.520
201512 4.259 102.901 6.329
201603 3.214 102.518 4.794
201606 0.260 105.961 0.375
201609 1.794 105.961 2.589
201612 2.431 105.196 3.534
201703 3.868 105.196 5.623
201706 4.342 107.109 6.199
201709 0.462 109.021 0.648
201712 0.571 109.404 0.798
201803 2.294 109.786 3.195
201806 2.636 111.317 3.621
201809 1.223 115.142 1.624
201812 8.778 115.142 11.658
201903 11.600 118.202 15.008
201906 0.820 120.880 1.037
201909 7.201 123.175 8.940
201912 7.782 126.235 9.427
202003 2.295 124.705 2.814
202006 1.381 127.000 1.663
202009 9.849 130.118 11.575
202012 1.931 130.889 2.256
202103 8.693 131.771 10.089
202106 3.396 134.084 3.873
202109 8.400 135.847 9.456
202112 1.006 138.161 1.113
202203 1.095 138.822 1.206
202206 7.758 142.347 8.334
202209 1.727 144.661 1.826
202212 0.896 145.763 0.940
202303 8.367 146.865 8.712
202306 1.495 150.280 1.521
202309 11.305 151.492 11.412
202312 3.236 152.924 3.236

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Biofil Chemicals & Pharmaceuticals  (BOM:524396) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Biofil Chemicals & Pharmaceuticals Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Biofil Chemicals & Pharmaceuticals's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Biofil Chemicals & Pharmaceuticals (BOM:524396) Business Description

Traded in Other Exchanges
Address
11/12, Sector E, Sanwer Road, Industrial Area, Indore, MP, IND, 452015
Biofil Chemicals & Pharmaceuticals Ltd is an Indian-based pharmaceutical company. The company's operating segment includes Pharma and Chemicals. It generates maximum revenue from the Pharma segment.

Biofil Chemicals & Pharmaceuticals (BOM:524396) Headlines

No Headlines